✍️ 🧑‍🦱 💚 Autor:innen verdienen bei uns doppelt. Dank euch haben sie so schon 431.453 € mehr verdient. → Mehr erfahren 💪 📚 🙏

Serum Intercellular Adhesion Molecules in Chronic Renal Failure

Serum Intercellular Adhesion Molecules in Chronic Renal Failure

von Ahmed Khalid Faleeh Aldhalmi, Arif Sami Malik und Yahya Yahya Zaki Fareed
Softcover - 9783659921339
36,90 €
  • Versandkostenfrei
Auf meine Merkliste
  • Hinweis: Print on Demand. Lieferbar in 2 Tagen.
  • Lieferzeit nach Versand: ca. 1-2 Tage
  • inkl. MwSt. & Versandkosten (innerhalb Deutschlands)

Autorenfreundlich Bücher kaufen?!

Beschreibung

The current study was conducted to verify the changes of the inflammatory and endothelial markers , i.e , Intercellular Adhesion Molecules (ICAM-1), Vascular cell Adhesion Molecules (VCAM-1), Endotheline (ET-1), Vascular Endothelial Growth Factor (VEGF) and C-Reactive Protein (CRP) serum levels in Chronic Renal Failure Patients receiving haemodialysis. To acheive this aim , Sixty five patients of CKD ( 29 females, 36 males) were enrolled in this study. They were admitted to the Artificial Kidney Units for heamodialysis in AL- Hakeem General Hospital and AL-Sadr Medical City in Annajaf City and compared with forty healthy subjects,18 of them were females and 22 were males .The range of ages of patients were 20 to 70 y and those of the control group were 25 to 65 y. Thirty (12 females, 18 males) from these patients were followed for up to six months (zero reading at 1st month and the others at 3rd month, at 5th month and 7th month) for serial assessment for estimation of serum levels of of ICAM-1, VCAM-1, ET-1,VEGF and CRP in the haemodialysis patients. Serum of ICAM-1, VCAM-1, ET-1, VEGF and CRP concentrations were measured by enzyme linked immuno-sorbent assay (ELISA).

Details

Verlag LAP LAMBERT Academic Publishing
Ersterscheinung 12. Juli 2016
Maße 22 cm x 15 cm x 1 cm
Gewicht 233 Gramm
Format Softcover
ISBN-13 9783659921339
Seiten 144

Widerrufsantrag einreichen

Füllen Sie das folgende Formular aus, um Ihren Widerrufsantrag einzureichen.